Defective STING signaling in low-grade serous ovarian cancer: an opportunity for oncolytic viruses therapy

被引：0
|
作者：
Zhantuyakova, Almira
Cochrane, Dawn
Negri, Gian Luca
Miko, Sandra Spencer
Azad, Taha
Fernandez, Marta Llaurado
Carey, Mark
Morin, Gregg B.
Bell, John
Huntsman, David D.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 05期
关键词：
D O I：
10.1158/1538-7445.OVARIAN23-B054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B054
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Low-grade serous ovarian carcinoma: an evolution toward targeted therapy
    Voutsadakis, Ioannis A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (10) : 1619 - 1626
  • [22] Management challenges in low-grade serous ovarian cancer with a BRCA mutation
    Sanchez-Lorenzo, Luisa
    Sancho, Lidia
    Iscar, Teresa
    Grisham, Rachel
    Chiva, Luis
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 631 - 636
  • [23] The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
    Crane, Erin K.
    Sun, Charlotte C.
    Ramirez, Pedro T.
    Schmeler, Kathleen M.
    Malpica, Anais
    Gershenson, David M.
    GYNECOLOGIC ONCOLOGY, 2015, 136 (01) : 25 - 29
  • [24] Treatment of Recurrent Low-grade Serous Ovarian Cancer With MEK Inhibitors
    Kulkarni, Anjali
    Cooke, Carly
    Fazelzad, Rouhi
    Fung-Kee-Fung, Michael
    May, Taymaa
    Zigras, Tiffany
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (01): : 11 - 16
  • [25] Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer
    Hacker, Kari E.
    Uppal, Shitanshu
    Johnston, Carolyn
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (09): : 1175 - 1182
  • [26] Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review
    Lazurko, Caitlin
    Linder, Revital
    Pulman, Kate
    Lennox, Genevieve
    Feigenberg, Tomer
    Fazelzad, Rouhi
    May, Taymaa
    Zigras, Tiffany
    CURRENT ONCOLOGY, 2023, 30 (09) : 8159 - 8171
  • [27] Identifying mechanisms of therapeutic resistance in low-grade serous ovarian cancer
    Nobre, Silvana Pedra
    Peplinski, Rebekah
    Schillo, Jacob
    Ulmer, Keely
    Riordan, Jesse
    Dupuy, Adam
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S305 - S305
  • [28] Targeting MAPK in recurrent, low-grade serous ovarian cancer Comment
    Blagden, Sarah P.
    LANCET, 2022, 399 (10324): : 499 - 501
  • [29] MEK inhibition for low-grade serous ovarian cancer: are we there yet?
    Scaranti, Mariana
    Mathias-Machado, Maria Cecilia
    Guo, Christina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 155 - 156
  • [30] BinimetinibAcquired resistance in low-grade serous ovarian cancer: case report
    Reactions Weekly, 2020, 1789 (1) : 67 - 67
12345